IP Verse

Swedish Orphan Biovitrum competitive analysis

Latest oppositions filed by Swedish Orphan Biovitrum

Explore patent oppositions filed by Swedish Orphan Biovitrum against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 9, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3564267
Proteolytically Cleavable Fusion Proteins With High Molar Specific ActivityCSL BEHRINGDec 17, 2021
EP3225233
Sodium Chloride Solution For Drug Reconstitution Or DilutionWYETHMay 14, 2020
EP2256135
Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation FactorCSL BEHRINGDec 13, 2019

Latest publications and patents of Swedish Orphan Biovitrum New

Explore the latest publications and patents granted to Swedish Orphan Biovitrum, showcasing their recent innovations and technological advancements.

Last updated on: Oct 8, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Swedish Orphan Biovitrum

EP3511339
Apr 9, 2025Polypeptides Binding To Human Complement C5Granted And Under Opposition

Latest PTAB cases involving Swedish Orphan Biovitrum

Discover the latest PTAB cases involving Swedish Orphan Biovitrum, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Swedish Orphan Biovitrum with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 9, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIOVERATIV THERAPEUTICS33 - 2
CSL BEHRING394 -